Panel Discussion: Establishing Partnerships to Develop, Commercialize, & Decentralize Companion Diagnostics for Unprecedented Global Impact
Time: 11:35 am
day: Day 3 Track C
Details:
- When should partnerships be optimized to leverage approval of and access to biomarker information?
- Maximizing market access through strategic partnerships with key stakeholders
- Understanding the value of consistent decentralized testing in the management of clinical trials
